NIH-funded research U01 cooperative agreement

Hyperbaric Oxygen for Brain Injury

Official title: Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial

Funded at Hennepin Healthcare Research Institute · NIH-11144113 · Data updated 2026-11-12

This research explores if giving extra oxygen in a special chamber can help people recover better after a severe brain injury.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionHennepin Healthcare Research Institute
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 30, 2017
Project endJune 30, 2029
Funding year2025
Award (this year)$1,740,714
NIH project number2U01NS095926-06
Project IDNIH-11144113 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be individuals who have recently experienced a severe traumatic brain injury.

Less likely to help

Patients with mild brain injuries or those whose injuries occurred a long time ago may not benefit from this acute treatment.

What this research studies

Severe brain injuries often lead to serious problems and even death, and current treatments haven't shown great success in large studies. This project looks at a treatment called hyperbaric oxygen, where you breathe pure oxygen in a pressurized room. The idea is that this extra oxygen can help heal the brain by improving blood flow, reducing swelling, and promoting new cell growth. This specific effort aims to figure out the best way to give this treatment to prepare for a larger study, by identifying optimal pressure and whether additional oxygen after treatment helps.

Why it matters

Potential benefit: If successful, this approach could lead to a new and effective treatment to improve recovery and reduce long-term problems for people with severe traumatic brain injury.

How similar studies have gone: Preclinical and early phase II clinical investigations have shown promising results, suggesting that hyperbaric oxygen may improve brain metabolism and neurological outcomes.

Where this research is happening

  • Hennepin Healthcare Research Institute
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Rockswold, Gaylan L — Hennepin Healthcare Research Institute
  • Study coordinator: Rockswold, Gaylan L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.